Since 2019 Kathleen has been actively involved with advocacy as a Metastatic Breast Cancer peer volunteer at SHARE Cancer Support. She began her volunteer work as a dedicated MBC helpline volunteer and MBC peer then added support group facilitator as well as OUR MBC Life podcast host and producer to her roles. Kate believes there is nothing better than being surrounded by peers “who get it.” She feels strongly that no-one with MBC should feel alone and everyone should have access to support. Kate is passionate about the needs of the community and strives to educate and empower people to advocate for the best possible care and quality of life.
Kate graduated with honors and earned a Master of Science degree in Healthcare Policy and Management, Community Health Education and Planning, an Advanced Certificate in Healthcare Management, and a Bachelor of Science degree in Occupational Therapy.
Kate recently accepted a position of Director of Metastatic Breast Cancer Program at SHARE Cancer Support. She is excited to use her science background as well as her MBC patient experience to continue the success of the metastatic breast cancer programs and is committed to developing new programs with the goal of improving patient experience and survivorship.
She dreams of driving a race car in Europe but until then she enjoys playing guitar, getting together with family and friends and getting away to the mountains any chance she can get.
Kate lives in New York with her husband and three sons.
Kathleen Pfitzer
Our annual “We Remember” episode honors all who died from metastatic breast cancer since last October and gives voice to the grief and love that endures after each death. Each name shared is a tiny marker of a full, messy, beloved life and each one leaves behind an expansive network of loved ones. For those of us in the MBC community, the loss of our friends is particularly devastating & the cumulative losses are heavy. You are not alone in your grief. We invite you to bear witness with us to this outpouring of love for those we have lost.
On today's episode, we are thrilled to discuss an important and often misunderstood area of oncology- biosimilars and their increasing use in cancer care. You might be curious, what exactly are biosimilars? How are they developed and approved? And most importantly, how are they transforming the lives of patients diagnosed with cancer? We will break down these questions and more as we explore this with an overview from Dr. Julie Gralow, a breast medical oncologist and chief medical officer at the American Society of Clinical Oncology.
We are thrilled to present an audio version of SHARE Cancer Support’s webinar “Report Back from ASCO 2024: Latest Updates on HR+ Metastatic Breast Cancer (MBC)”.
This episode is an in-depth report from the ASCO 2024 Annual Meeting, featuring the latest advancements and research in HR+ MBC. Hear from Dr. Kevin Kalinsky as we dive into the findings from the DESTINY-Breast06 and postMONARCH trials, exploring their implications and potential impact on treatment strategies.
There’s a lot of research about how diet and exercise can have a positive effect on survivorship for those with early-stage breast cancer, but about for those of us with MBC? In this episode, we are delighted to bring you a conversation with Dr. Neil Iyengar, a prominent oncologist and researcher known for his deep interest in how lifestyle affects a variety of outcomes. Emerging research and patient experiences are showing that exercise and diet can play a vital role in improving quality of life and may even enhance treatment outcomes. We discuss the science behind diet and exercise along with strategies for balancing lifestyle changes while prioritizing what matters most to us. Whether you’re a patient, a caregiver, or a healthcare professional, this episode is packed with valuable information and insights!
Today’s episode is the first in a three part series covering all things related to bone metastasis. In this episode, we discuss the basics with Dr. Azeez Farooki and Dr. Monica Fornier, both specialists in their fields at MSK, diving into the latest breakthroughs in bone disease and breast cancer research. Topics include theories on why breast cancer spreads to the bones, as well as new drug protocols shaping the future of bone metastasis research and treatment. We unlock the wisdom of these top experts as they bridge the gaps between advancing research and patient care in a thought provoking conversation.
Today we are bringing you a special episode that we created in partnership with SHARE Cancer Support. It’s an audio version of a live webinar that was done this past February called Report Back from San Antonio Breast Cancer Symposium 2023. SABCS is the world’s leading breast cancer research meeting where scientists, patient advocates, and others dedicated to working in the field of cancer gather. In this podcast, Dr. Timothy Pluard highlighted promising research, targeted therapy, the evolving treatment after CDK 4/6 inhibitors, liquid biopsy and more.
Today we are bringing you a special podcast that we created in partnership with SHARE Cancer Support called Understanding Progression: How to Identify and Treat ESR1 Mutations in HR+ MBC. This episode was produced from a live webinar from this past October. There has not been a new endocrine treatment in decades and many of us find out the endocrine treatment no longer works for us because the cancer has mutated. Kate Vieira Pfitzer and Victoria Goldberg are excited to bring Dr. Virginia Kaklamani to you. You will hear her explain this common problem, how to test for it, the new treatment option that is now available as well as many of the ongoing clinical trials for HR+ MBC.
Anne Woodward sits down with a special guest to discuss the in’s and outs of having MBC while living in the public eye. Get ready folks, pull up a chair you are not going to want to miss hearing from Kelly Crump, the first ever sports illustrated swimsuit model photographed while posing on a picturesque beach in a gorgeous swimsuit with a mastectomy scar for all the world to see. In this incredible interview Kelly explains how she embraced social media to live out loud and in doing so harnessed all the attention to be an inspiration and help her 30,000 + followers.
This season, we are bringing back our Trailblazer series. Our first trailblazer is Living Beyond Breast Cancer (LBBC), a national non-profit that has become synonymous with the word community. That’s because LBBC’s annual Conference on MBC is one of the largest gatherings for women and men living with MBC. In this episode we will speak with Jean Sachs, CEO of LBBC, and sprinkled throughout this episode are your voices, voices of patients sharing their LBBC experience.
Welcome to the second part of our post–2022-ASCO analysis of the state of affairs in the HR-positive MBC. It was not so long ago that our only options were single-agent endocrine therapy and systemic chemo. We have come a long way over the last couple of decades. Today we are asking Drs. Stephanie Graff, Sara Hurvitz, and Kevin Kalinsky to talk about how they make decisions in the clinic in selecting and sequencing treatments, specifically CDK4/6 inhibitors and the newly approved targeted therapies.
The DESTINY-Breast04 trial at ASCO 2022 introduced many people to the term “HER2-low.” But how do you know if you’re HER2-low? In this episode, with the help a breast pathologist and a clinical oncologist we dive into this subtype and what it means to us.
Endocrine therapy is an effective way to treat hormone-sensitive breast cancers, but de novo and acquired resistance to this treatment remains a major challenge. In this episode, the Our MBC Life team hears from two dynamic MSK oncologists Dr. Pedram Razavi and Dr. Komal Jhaveri on treatment strategies and the latest research around the problem of endocrine resistance.
What does it mean when our cancer shows progression? And how do we know when that happens? The Our MBC Life team gets the lowdown from Dr. Stephanie L. Graff.
What can we, as patients, do to strengthen our communication and relationships with our oncologists? This episode of Our MBC Life, the first in our MBC 101 series, includes perspectives, insights and suggestions from both sides of the critical doctor-patient relationship
The Road to a Cure series gets on the redeye to LA to have Senior Producer and Co-host, Victoria Goldberg and co-host Kate Pfitzer speak with Dr. Sara Hurvitz. She talks about her perspective on where we are as we work for a cure, the HER2+ studies she is excited about, and other research that is intriguing as it relates to all subtypes
The podcast team has embarked upon something quite ambitious. The members of the team have traveled virtually to speak with the leading clinicians and researchers in the field of breast cancer, specifically on the topic of where we are in terms of a cure for metastatic breast cancer. It is impossible to cover it in a neat single episode, so, instead, we created a very special series of episodes that we call “Road to A Cure.” In this premiere episode the members of the creative team share with the audience what it means to live with an incurable disease. We talk about a possibility of a cure, address the real fear of hoping, and tackle these and many other important issues.
Hosted, Produced, Participated In…
Metastatic Program Director for SHARE, Senior Producer, Host
Many people are unfamiliar with Postpartum Breast Cancer (PPBC), a little-known subset of breast cancer that occurs in women within 10 years of childbirth. This episode of our podcast delves into this personal topic for several members of our team.
Drs. Virginia Borges and Pepper Schedin are launching the first-ever clinical trial to prevent PPBC. Their groundbreaking approach involves giving healthy new mothers a brief course of ibuprofen as they wean their babies from breastfeeding. This trial holds huge potential for global impact, and the doctors need the public’s help to make it happen.